Tissue-engineered intervertebral disc with living cells
Abstract
The present invention relates to a tissue-engineered intervertebral disc (IVD) suitable for total disc replacement in a mammal and methods of fabrication. The IVD comprises a nucleus pulposus structure comprising a first population of living cells that secrete a hydrophilic protein and an annulus fibrosis structure surrounding and in contact with the nucleus pulposus structure, the annulus fibrosis structure comprising a second population of living cells and type I collagen. The collagen fibrils in the annulus fibrosis structure are circumferentially aligned around the nucleus pulposus region due to cell-mediated contraction in the annulus fibrosis structure. Also disclosed are methods of fabricating tissue-engineered intervertebral discs.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A method of fabricating a tissue-engineered intervertebral disc (IVD), said method comprising:
providing a first gel comprising a first population of living cells; forming the first gel into a predetermined shape and size; providing a second different gel comprising a second different population of living cells and collagen; contacting the formed first gel with the second gel at a region that extends circumferentially around the first gel; and storing the first and second gels under conditions effective for the collagen in the second gel to align circumferentially around the first gel by self-assembly of collagen due to cell-mediated gel contraction in the second gel, wherein the first gel forms a nucleus pulposus structure and the second gel forms an annulus fibrosus structure surrounding and in contact with the nucleus pulposus structure, thereby fabricating a tissue-engineered IVD suitable for total disc replacement in a mammal.
3 . The method according to claim 2 , wherein the first gel is an alginate gel comprising about 0.5% to about 10% (w/v) alginate.
4 . The method according to claim 2 , wherein the first population of cells is present in the first gel at a concentration of about 1×10 6 to about 50×10 6 cells/ml.
5 . The method according to claim 2 , wherein the first population of cells secrete a proteoglycan.
6 . The method according to claim 2 , wherein the first population of cells comprises nucleus pulposus cells.
7 . The method according to claim 2 , wherein the first gel further comprises type II collagen.
8 . The method according to claim 2 , wherein the nucleus pulposus has an isotropic structure.
9 . The method according to claim 2 , wherein the second population of cells comprises annulus fibrosus cells.
10 . The method according to claim 2 , wherein the second population of cells are present in the second gel at a concentration of about 0.1-5.0×10 7 cells/ml.
11 . The method according to claim 2 , wherein the second gel comprises collagen at a concentration of about 1 mg/ml to about 30 mg/ml.
12 . The method according to claim 2 , wherein the annulus fibrosus has an anisotropic structure.
13 . The method according to claim 2 , wherein the IVD is permeable to allow nutrient transport to developing tissue.
14 . The method according to claim 2 further comprising:
cross-linking the first gel.
15 . The method according to claim 2 , wherein the second gel is formed at a temperature of about 25° C. to about 37° C.
16 . The method according to claim 2 , wherein said storing is carried out for about 3 to about 28 days.
17 . The method according to claim 2 , wherein said forming is carried out by injection molding or by cutting samples from a sheet.
18 . A method of fabricating a tissue-engineered intervertebral disc (IVD), said method comprising:
providing a first gel comprising a first population of living cells; providing a second different gel comprising a second different population of living cells and collagen; forming the second gel around a central mandrel structure; storing the second gel under conditions effective for the collagen in the second gel to align circumferentially around the central mandrel structure by self-assembly of collagen due to cell-mediated gel contraction in the second gel; replacing the central mandrel structure with the first gel, wherein the first gel forms a nucleus pulposus structure and the second gel forms an annulus fibrosus structure surrounding and in contact with the nucleus pulposus structure, thereby fabricating a tissue-engineered IVD suitable for total disc replacement in a mammal.
19 . The method according to claim 18 , further comprising:
forming the first gel into a predetermined shape and size.
20 . The method according to claim 18 , wherein the central mandrel structure comprises plastic or metal.
21 . The method according to claim 18 , wherein said forming is carried out by injection molding or by cutting samples from a sheet.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.